Typhim Vi PFS 0.025mg/0.5ml 1s

Typhim Vi PFS (Typhoid Vi Polysaccharide Vaccine) is a sterile, colorless, clear to slightly opalescent solution for intramuscular use, designed to provide active immunization against typhoid fever for individuals two years of age and older. The vaccine is formulated without preservatives and is presented in a pre-filled syringe (PFS) for ease of administration.

Technical Specifications:
- Active Ingredient: Vi capsular polysaccharide of Salmonella typhi (Ty2 strain)
- Concentration: 0.025mg of polysaccharide per 0.5ml dose
- Formulation: Pre-filled syringe, single-dose
- Storage: Refrigerate at 2°C to 8°C (35°F to 46°F)
- Shelf Life: Check packaging for the expiration date
- Administration: Intramuscular injection, preferably in the deltoid muscle

Common Applications and User Groups:
- Travelers to regions where typhoid fever is endemic
- Individuals living in or moving to endemic areas
- Laboratory personnel who handle Salmonella typhi organisms
- Individuals with increased exposure risk due to work or personal circumstances

Overview of Sanofi Pasteur:
Sanofi Pasteur, the vaccines division of the global healthcare company Sanofi, is a leading authority in the vaccine industry. With over a century of experience in vaccine innovation and production, Sanofi Pasteur offers a broad range of vaccines protecting against 20 infectious diseases. The company's dedication to public health and commitment to high-quality manufacturing practices ensures that products like Typhim Vi PFS meet the highest standards of safety and efficacy. Sanofi Pasteur's expertise in the field of vaccine research and development positions them as a trusted supplier of vaccines for typhoid fever and other preventable diseases.